Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
1. Needham upgraded Inogen from Hold to Buy with a $12 target. 2. Q1 revenue reached $82.3 million, a 5.5% year-over-year increase. 3. New management strategies are driving mid-single-digit revenue growth. 4. Expect further growth acceleration in late 2025 and 2026. 5. Margins expected to improve with stabilization of direct-to-consumer sales.